Canada has enjoyed a reputation for excellence in the area of clinical research. Our participation and leadership in clinical trials has led to many world first medical discoveries and innovations; attracted world leading clinicians and researchers; benefited patients and families; and resulted in important pay-offs for our economy.
However, there are operational barriers that could compromise our future success. We are seeing a decreased number of clinical trial applications in Canada and an increase in the impact of issues related to the cost, quality and time required to conduct clinical trials in our country. These need to be addressed in order to re-establish and secure the future human, social and financial benefits from clinical trials that we currently enjoy.